Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bulky Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00664144
What this trial is testing

Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma

Who this might be right for
Hyperuricemia
Sanofi 33
Testing effectiveness (Phase 2)Ended earlyNCT00765570
What this trial is testing

Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy

Who this might be right for
Advanced Bulky Malignancies
Summa Health System 12
Not applicableLooking for participantsNCT05421650
What this trial is testing

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Who this might be right for
Cervical Cancer
CHA University 240
Testing effectiveness (Phase 2)Study completedNCT00496873
What this trial is testing

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 100
Early research (Phase 1)UnknownNCT04881981
What this trial is testing

A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer

Who this might be right for
Malignant Neoplasms
Baptist Health, Louisville 12
Testing effectiveness (Phase 2)Ended earlyNCT03661567
What this trial is testing

Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 52
Not applicableLooking for participantsNCT06898905
What this trial is testing

Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma
Yale University 10
Early research (Phase 1)Ended earlyNCT03114319
What this trial is testing

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)+4 more
Novartis Pharmaceuticals 227
Testing effectiveness (Phase 2)Study completedNCT01392716
What this trial is testing

MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 48
Large-scale testing (Phase 3)Looking for participantsNCT05699655
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
Immunotherapy Gastrict Cancer
Fujian Cancer Hospital 130
Testing effectiveness (Phase 2)Looking for participantsNCT06104592
What this trial is testing

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Who this might be right for
Large B-cell LymphomaRelapsed Non-Hodgkin Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT01534078
What this trial is testing

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06704555
What this trial is testing

Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06936748
What this trial is testing

SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors

Who this might be right for
Cancer
Second Affiliated Hospital of Nanchang University 30
Not applicableStudy completedNCT05318170
What this trial is testing

Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps (Yasargil-1)

Who this might be right for
Gynecologic Cancer
University of Palermo 43
Not applicableLooking for participantsNCT07423169
What this trial is testing

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

Who this might be right for
Lung AdenocarcinomaBulky TumorsUnresectable Cancer
Karl Landsteiner University of Health Sciences 10
Testing effectiveness (Phase 2)Study completedNCT05223088
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
ImmunotherapyGastrict Cancer
Fujian Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03659578
What this trial is testing

Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 69
Not applicableEnded earlyNCT01054911
What this trial is testing

Evaluation of Patients With Bulky GIST Using Sunitinib

Who this might be right for
Tumor
University of Alabama at Birmingham 5
Not applicableStudy completedNCT00850200
What this trial is testing

Proton Therapy for Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Florida 20
Next Page